A Nonrandomized Pilot Study to Investigate the Acceptability and Feasibility of LivR Well: A Multifaceted 28-Day Home-Based Liver Optimization Program for Acute-on-Chronic Liver Failure
LivR Well was acceptable, feasible, and safe with low short-term mortality and readmission rates. Health-care costs were reduced by 26% driven by a 40% reduction in 30-day readmission. Further evaluation includes a randomized controlled trial of LivR Well compared to standard care.
Authors
- Declan Connoley (ORCID: https://orcid.org/0000-0003-1440-1756)
- Thomas Worland (ORCID: https://orcid.org/0000-0001-5122-5750)
- Danny Liew (ORCID: https://orcid.org/0000-0002-0131-623X)
- Patricia S. Anderson
- Imogen Hartley (ORCID: https://orcid.org/0009-0002-7325-1313)
- Lisa Stothers
- Suong Le (ORCID: https://orcid.org/0000-0003-3305-4999)
- Benjamin A. Rogers (ORCID: https://orcid.org/0000-0001-6515-2118)
- Edward Saxby (ORCID: https://orcid.org/0000-0001-8155-124X)
- Alexander T. Elford (ORCID: https://orcid.org/0000-0001-6144-1369)
- Andrew T. Roberts (ORCID: https://orcid.org/0000-0002-0387-6775)
- Phil Ha (ORCID: https://orcid.org/0000-0002-4317-2529)
- William Sievert (ORCID: https://orcid.org/0000-0001-7829-0974)
- Dean Seah (ORCID: https://orcid.org/0000-0003-3317-1888)
- Anita Figredo
- Natalie L. Y. Ngu (ORCID: https://orcid.org/0000-0002-9383-3903)
- George Tambakis (ORCID: https://orcid.org/0000-0001-8785-7661)
- Sally Bell (ORCID: https://orcid.org/0000-0002-7002-453X)
- Dilip Ratnam
- JO Hunter
Institutions
- The University of Melbourne (AU)
- Monash Health (AU)
- Monash University (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Gastro Hep Advances
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.gastha.2024.10.007
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.37